Analysts See $-0.70 EPS for Neos Therapeutics (NEOS); Cheesecake Factory (CAKE) Shorts Raised By 0.8%

November 4, 2017 - By Hazel Jackson

Cheesecake Factory Incorporated (NASDAQ:CAKE) had an increase of 0.8% in short interest. CAKE’s SI was 10.75 million shares in November as released by FINRA. Its up 0.8% from 10.67M shares previously. With 1.30M avg volume, 8 days are for Cheesecake Factory Incorporated (NASDAQ:CAKE)’s short sellers to cover CAKE’s short positions. The SI to Cheesecake Factory Incorporated’s float is 25.42%. The stock increased 3.03% or $1.28 on November 3, reaching $43.46. About 1.92M shares traded or 30.61% up from the average. Cheesecake Factory Inc (NASDAQ:CAKE) has risen 21.63% since November 4, 2016 and is uptrending. It has outperformed by 4.93% the S&P500.

Analysts expect Neos Therapeutics Inc (NASDAQ:NEOS) to report $-0.70 EPS on November, 9.They anticipate $0.91 EPS change or 56.52% from last quarter’s $-1.61 EPS. After having $-0.83 EPS previously, Neos Therapeutics Inc’s analysts see -15.66% EPS growth. The stock increased 27.09% or $2.75 on November 3, reaching $12.9. About 1.58M shares traded or 84.51% up from the average. Neos Therapeutics Inc (NASDAQ:NEOS) has risen 9.07% since November 4, 2016 and is uptrending. It has underperformed by 7.63% the S&P500.

Investors sentiment increased to 1.28 in 2017 Q2. Its up 0.18, from 1.1 in 2017Q1. It improved, as 40 investors sold Cheesecake Factory Inc shares while 76 reduced holdings. 46 funds opened positions while 102 raised stakes. 44.64 million shares or 1.12% less from 45.15 million shares in 2017Q1 were reported. Bridgewater Assoc Limited Partnership has 12,056 shares for 0.01% of their portfolio. Royal Comml Bank Of Canada invested 0% in Cheesecake Factory Inc (NASDAQ:CAKE). 75,100 are held by Swiss National Bank & Trust. Stevens Capital Mgmt Lp reported 0.02% in Cheesecake Factory Inc (NASDAQ:CAKE). Barclays Public Ltd Co holds 18,963 shares or 0% of its portfolio. Huntington Natl Bank accumulated 641 shares or 0% of the stock. State Board Of Administration Of Florida Retirement System stated it has 34,552 shares or 0% of all its holdings. Texas Permanent School Fund reported 0.02% in Cheesecake Factory Inc (NASDAQ:CAKE). Weaver C Barksdale And Assoc Inc holds 229 shares or 0.01% of its portfolio. Bnp Paribas Asset Management Holdg stated it has 0.02% of its portfolio in Cheesecake Factory Inc (NASDAQ:CAKE). Global X Limited Liability accumulated 363 shares. Ameriprise Financial holds 0.01% of its portfolio in Cheesecake Factory Inc (NASDAQ:CAKE) for 227,025 shares. Columbia Prtnrs L L C Invest Mgmt has 26,900 shares for 0.17% of their portfolio. Hbk Investments Lp stated it has 54,300 shares. Ubs Asset Mgmt Americas has invested 0% in Cheesecake Factory Inc (NASDAQ:CAKE).

The Cheesecake Factory Incorporated is engaged in the restaurant and bakery business. The company has market cap of $2.04 billion. As of March 2, 2017, the Company operated 208 Company-owned restaurants: 194 under The Cheesecake Factory mark, 13 under the Grand Lux Cafe mark and one under the Rock Sugar Pan Asian Kitchen mark. It has a 16.03 P/E ratio. The Company’s divisions include The Cheesecake Factory restaurants, and other.

Since May 23, 2017, it had 1 insider purchase, and 2 selling transactions for $711,223 activity. ZURZOLO DEBBY R had sold 6,000 shares worth $354,892 on Tuesday, May 23. 400 shares were bought by PITTAWAY DAVID BRUCE, worth $23,288 on Tuesday, May 23.

Among 18 analysts covering The Cheesecake Factory Incorporated (NASDAQ:CAKE), 4 have Buy rating, 1 Sell and 13 Hold. Therefore 22% are positive. The Cheesecake Factory Incorporated had 54 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Cheesecake Factory Inc (NASDAQ:CAKE) earned “Buy” rating by Piper Jaffray on Thursday, August 3. Stephens maintained it with “Equal-Weight” rating and $45 target in Wednesday, October 11 report. As per Thursday, July 23, the company rating was maintained by Wunderlich. The stock of Cheesecake Factory Inc (NASDAQ:CAKE) has “Buy” rating given on Tuesday, October 27 by Stifel Nicolaus. The rating was maintained by Telsey Advisory Group with “Outperform” on Thursday, February 23. The stock has “Equal-Weight” rating by Barclays Capital on Wednesday, July 19. The stock has “Equal-Weight” rating by Stephens on Wednesday, November 16. On Wednesday, September 6 the stock rating was maintained by Robert W. Baird with “Hold”. Canaccord Genuity maintained Cheesecake Factory Inc (NASDAQ:CAKE) on Friday, October 20 with “Hold” rating. Nomura maintained the shares of CAKE in report on Thursday, November 2 with “Neutral” rating.

Neos Therapeutics, Inc. is a pharmaceutical company. The company has market cap of $362.24 million. The Firm is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. It currently has negative earnings. The Company’s segment is engaged in the development, manufacturing and commercialization of pharmaceuticals.

Among 7 analysts covering Neos Therapeutics (NASDAQ:NEOS), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Neos Therapeutics had 20 analyst reports since August 17, 2015 according to SRatingsIntel. As per Monday, August 17, the company rating was initiated by RBC Capital Markets. The stock of Neos Therapeutics Inc (NASDAQ:NEOS) has “Outperform” rating given on Thursday, November 12 by RBC Capital Markets. The firm has “Neutral” rating by UBS given on Monday, March 20. The stock of Neos Therapeutics Inc (NASDAQ:NEOS) earned “Outperform” rating by Wells Fargo on Friday, February 19. Cantor Fitzgerald maintained the shares of NEOS in report on Wednesday, August 9 with “Buy” rating. The firm has “Outperform” rating given on Monday, August 17 by BMO Capital Markets. RBC Capital Markets maintained the shares of NEOS in report on Tuesday, August 8 with “Buy” rating. BMO Capital Markets maintained the shares of NEOS in report on Friday, September 15 with “Buy” rating. On Wednesday, June 29 the stock rating was initiated by BMO Capital Markets with “Outperform”. The firm has “Market Outperform” rating by JMP Securities given on Wednesday, March 9.